Cole Foundation invests $1 million in new leukemia research

    McGill University, Université de Montréal establish a program of
    post-graduate fellowships

    MONTREAL, March 5 /CNW Telbec/ - McGill University and Université de
Montréal today announced the creation of a series of post-graduate research
fellowships aimed at finding a cure for leukemia and other cancer-related
illnesses. The fellowship program is made possible by a generous investment
from the Cole Foundation, a Montreal-based non-profit organization dedicated
to promoting research to eradicate leukemia.
    The initial fellowship program will last 16 months and will spread
$1 million among 28 individual clinician scientists, post-doctoral researchers
and students in the doctoral and master's programs. Of the 28 recipients, 18
are associated with various medical departments at Université de Montréal or
with research laboratories at Le Centre Hospitalier de l'Université de
Montréal - Ste. Justine Research Centre, Institute for Research in Immunology
and Cancer and Hôpital Maisonneuve-Rosemont. The remaining 10 fellowships are
divided among the McGill University Health Centre - namely the Montreal
Children's Hospital Research Centre, the Royal Victoria Hospital and the
Montreal Neurological Institute - as well as the Lady Davis Research Centre at
the Jewish General Hospital and various medical departments at McGill.
Subsequent fellowship awards are expected to last two years and will be funded
with approximately $1,000,000 each year.
    "The Cole Foundation's notable investment in leukemia research at McGill
and Université de Montréal will enable both institutions to attract the best
researchers to help us achieve our common goal, which is to one day find a
cure for all forms of leukemia and related diseases," said Dr. Richard Levin,
Vice-Principal, Health Affairs, and Dean of the Faculty of Medicine at McGill.
    "Thirty years ago, four out of five children suffering from acute forms
of leukemia would die. Today, research has reversed that situation: four out
of five children survive but these children are susceptible to secondary
diseases and conditions later in life," explained Dr. Jean L. Rouleau, Dean of
the Faculty of Medicine at Université de Montréal. "Continuous follow-up is
one of several objectives set by pediatric oncology and hematology research
teams. Thanks to the essential and vital support of the Cole Foundation, our
researchers are enabled to pursue this fight."

    The Cole Foundation was created in 1980 by Montreal businessman
John N. (Jack) Cole to support Montreal hospitals and research in pediatric
oncology and hematology. After his only child, Penny, died of leukemia on her
20th birthday, Mr. Cole established the Penny Cole Laboratory at the Montreal
Children's Hospital. The purpose of the lab was to foster research into the
causes and potential cures for leukemia and other related diseases affecting
children. In 1997, the Cole Foundation also endowed the Jack Cole Chair of
Pediatric Oncology and Hematology at McGill University.
    "Over the past 25 years, the Cole Foundation has contributed millions of
dollars to the Montreal medical community," said Don Sinclair, President of
the Cole Foundation. "The Foundation's mission is to help find a cure for
leukemia. With this fellowship program at both universities, our objective is
to make Montreal a Centre of Excellence for leukemia research. Through the
collaborative efforts of both universities and the researchers themselves, we
hope to accelerate the search for better medical care for all patients
afflicted with this terrible disease."

    On the Web:

For further information:

For further information: Michael Bourguignon, McGill University
Relations Office, (514) 398-8305,; Julie
Gazaille, Press Officer, Université de Montréal, (514) 343-6796,; Source: John Moran, Cole Foundation

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890